Watch and Listen to our Demo Video



NES Health Research

Founded in 2003, NES Health Infoceuticals and miHealth have impacted the lives of people around the world. We know how powerful our solutions are. Our practitioners know as well. But we understand that research is key to building confidence in bioenergetics, which is so new, so unique, and so ready to revolutionize the world.

That's why we've had a number of studies done and are looking to expand on our research as well. Health science is steadily changing from its reductionist, mechanistic worldview to a new paradigm based on the findings of quantum physics and information medicine.

Our goal is to work with external organizations and individuals, or with academic institutions, to generate quality scientific evidence that supports the science behind bioenergetic and informational therapy and that demonstrates the efficacy of the BioEnergetiX WellNES System and its range of health products and overall therapeutic approach.

If you are a credentialed researcher interested to do clinical trials / case studies, or otherwise study the effects of NES Health products, please get in touch and let us know what you have in mind.

Research Highlights

2022 University Research

A university research team studied several different effects of Infoceuticals (and even direct imprinting of our information into cells) to validate what they could do in live tissue. Results included increased mitochondrial protection, reduced cellular stress, alterations to the cellular membrane, viral protection, and more.

Research results are here.

Study on NES Health Accuracy (vs. Other Devices) and Infoceutical Effectiveness

In a large-scale comparative study carried out by the Centre for Biofield Sciences under the supervision of Dr. Thornton Streeter, 96.5% of the 240 participants in the control group experienced a positive change (compared to 35% in the placebo group).

As measured using the MYMOP2 assessment form, the NES Infoceuticals reduced depressed feelings, stress, and premenopausal mood swings. They also increased emotional stability and a sense of calmness.

The study also demonstrated the efficacy of the NES ProVision software [precursor to our current BWS software] to highlight energetic distortions, demonstrating that it was comparable to the combined abilities of 3 energy measurement devices: PIP (polycontrast interference photography), GDV (gas discharge visualisation) and EIS (electro-interstitial scan).

Research results are here.

NES miHealth Shows 93% Effectiveness in Outcome Study

We conducted a large Outcome Study for miHealth that included 251 subjects and which collected data across 367 data points. In the study, 88% of the participants benefited from the NES miHealth therapy at the initial consultation.

Additionally, the positive effect on general rejuvenation was compounded on the second and third therapy sessions so that the subjects saw an increasing trend toward wellness.

You can explore the results from The NES miHealth Outcome study here.

NES Infoceuticals Effective in Reducing Depressed Feelings and Stress

A 6-month, double-blind, placebo-controlled study carried out by Desiree Del Monte, under the supervision of renowned energy medicine researcher, Dr. Norman Shealy, at Holos University, USA, showed that the NES Infoceuticals led to a reduction in depression scores and self-reported stress measures in 54 subjects.

Results based on the self-administered pre- and post- tests indicated difference in stress scores over time, showing that participants had lower scores post-therapy than they did pre-therapy.

Research results are here.

Infoceuticals Shown to Improve Mean Arterial Pressure Readings

A case study of 5 participants explored the impact of NES Health Infoceuticals on the health and wellbeing of people with a variety of physical complaints. This was undertaken as a master’s degree research project under the supervision of Professor Anna van Wersch for the University of Teesside.

The Infoceuticals had a positive physiological effect throughout the intervention period as determined using mean arterial pressure readings, which measures blood flow, resistance, and pressure with the arteries, and is an important indicator of cardiovascular health.

Research results are here.

NES Health Infoceuticals Significantly Improved Quality of Life, Increase Body Lean Mass, and Reduce Body Fat

Seven overweight/obese (1 male and 6 female) volunteers, mean age 42 years, participated in a two month case study, in which participants followed Infoceutical protocols without any change in diet or exercise.

At the end of two months, all participants reported higher IWQOL-Lite (quality of life) scores than their baseline scores (changes ranged from 1.9-18.3), and four of the seven participants demonstrated clinically meaningful change. Bioelectrical Impedance Analysis (BIA) revealed a decreased body fat mass index (BFFM) and body fat percentage and an increase of their lean mass, fat free mass index (FFMI) and body water respectively.

Research results are here.


ME/Chronic Fatigue Syndrome Research Study

A study of 9 participants with ME / Chronic Fatigue Syndrome showed promising results. The majority of participants experienced improvement in both symptoms and activities over the course of the study. This study provides a foundation for the exploration of NES as a complementary therapy in the reduction of negative symptoms of ME/CFS.

You can download the EDMESH Research Paper here.

The Use of the NES miHealth for Shift Workers

A clinical study involving 6 participants examined whether use of the NES miHealth would lead to a reduction in the physical problems associated with working nightshifts.

A trend of improvement of most vitality signs was observed, with data showing an improvement in sleep, weight control and energy parameters. The best result was that, after the miHealth intervention, the subjects were better able to make the change from nightshifts to dayshifts, and reported that the nightshift was easier and involved less energy and effort.

More details on the Shift Worker Trial can be downloaded here.


Study to Assess the Use of NES miHealth ‘MIND Functions’ with the Meta-Healing Process

The aim of this study was to assess whether or not the NES miHealth was an effective adjunct tool for resolving conflict shocks during meta-healing therapy. The method used to collect the data was an online self-assessment questionnaire. 60 participants took part in this study, 48 female and 12 male. Results showed that, for all variables, an improvement in main presenting issue was obtained. The greatest difference in scores was seen for Emotional issues and Digestion issues.

An overview of the research report can be downloaded here.


Observational Study Using NES Provision Scan Protocols and Measuring Heart Rate Variability (HRV)

This study of 8 participants suggests that NES Health Infoceuticals have a positive effect on autonomic function as measured by Heart Rate Variability (HRV) scores.

Research results are here.

Wellness Score & Symptom Severity Improvement Research

We implemented short, self-reporting questionnaires into our cloud system to gather data on symptoms associated with energy/fatigue, pain, sleep, and stress/anxiety. We identified pre/post-visit effects on Wellness Scores (WS) and Symptom Severity (SS). This study included ~6,000 participants with 2 visits or more; ~3000 participants with 3 visits or more; and ~1800 participants with 4 visits or more.

Those who began their protocols with a low "Wellness Score" saw statistically significant improvements.

Research results are here.


Infoceuticals & Viral Protection

Early laboratory testing has shown exciting results about how Infoceuticals may protect cells against viral penetration. They were tested against two controls, both of which demonstrated no protection, while the Infoceutical protection was obvious, even under extreme dilution. Click here to get the details.

Infoceutical Viral Protection


Case Study: Chronic Fatigue & Age-Related Macular Degeneration

This study showed a dramatic self-reported decline of exhaustion and fear of blindness over 6 months, alongside an increased definition in clarity and contrast, in particular with printed text.

Research results are here.